Home Tags FDA Approved

Tag: FDA Approved

Marijuana stock GW Pharmaceuticals nabs DEA Schedule V

9/27/18--The Drug Enforcement Agency (DEA) has awarded GW Pharmaceuticals' epilepsy drug, Epidiolex, Schedule V status, its least restrictive classification. The decision clears the way for GW Pharmaceuticals to begin offering the only CBD oil that's cleared by the DEA for use nationwide, and it puts the company on a path to disrupt how doctors treat patients who fail to respond to existing anti-epilepsy medications. Read

GW Pharmaceuticals reports fiscal third quarter 2018 financial results and operational progress

8/7/18--GW Pharmaceuticals, the world leader in the development and commercialization of cannabinoid prescription medicines, announces financial results for the third quarter, in addition to addressing the significance of FDA approval of Epidiolex®. Read